Among the nearly 20 leaders in health care presenting will be: Patrick Hanaway, MD, and Mark Hyman, MD, of Cleveland Clinic Center for Functional Medicine; Charles Serhan, PhD, from Harvard Medical School; and Giselle Sholler, MD, MSC, of Helen DeVos Children’s Hospital.
Jeffrey S. Bland, PhD, FACN, CNS, founder of PLMI, author of The Disease Delusion, and considered the “father of functional medicine,” is chairing the conference. “We are pleased to collaborate with CTCA® and bring together global leaders in personalized precision medicine to better understand the future of 21st century health care and the role that personalized lifestyle programs will play in its evolution. An ever-growing body of empirical research is demonstrating how specific genes are involved in the development of cancer,” he added. “With this recognition, personalized medicine is a natural extension.”
For more information about the program agenda, speakers and registration, visit www.plminstitute.org.
The Personalized Lifestyle Medicine Institute (PLMI) is a not-for-profit entity whose mission is to transform healthcare through the promotion of information, innovation, and implementation of personalized lifestyle medicine. The organization cultivates virtual and in-person networks of collaboration between researchers, clinicians, patients, policy makers, and consumer advocates to bring personalized lifestyle medicine into greater visibility. Additionally, it provides cutting-edge communication about the latest developments in personalized lifestyle medicine through their website and other educational endeavors. By harnessing the interest and input of individuals, thinkers, and innovative leaders, they strive to be global leaders in the emerging field of healthcare. For more information, visit www.plminstitute.org.
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America Global, Inc. (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-based supportive therapies designed to help patients physically and emotionally by enhancing their quality of life while managing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Consistently rated among U.S. hospitals that deliver the highest quality of care and patient experience, CTCA provides patients and their families with comprehensive information about their treatment options and encourages their active participation in treatment decisions. For more information, visit cancercenter.com, Facebook.com/cancercenter and Twitter.com/cancercenter.
Contact: Ellen Crane
Office: (561) 923-3149
SOURCE Cancer Treatment Centers of America